Imatinib, a tyrosine kinase inhibitor used in the treatment of gastrointestinal stromal tumor (GIST), has demonstrated inhibition of IDO expression in GIST mouse models [140]. This evidence concerns the gene IDO1 and gastrointestinal stromal tumor.